Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Activation and tolerance in CD4(+) T cells reactive to an immunoglobulin variable region.

Snyder CM, Aviszus K, Heiser RA, Tonkin DR, Guth AM, Wysocki LJ.

J Exp Med. 2004 Jul 5;200(1):1-11. Epub 2004 Jun 28.

2.

Self-tolerance checkpoints in CD4 T cells specific for a peptide derived from the B cell antigen receptor.

Detanico T, Heiser RA, Aviszus K, Bonorino C, Wysocki LJ.

J Immunol. 2011 Jul 1;187(1):82-91. doi: 10.4049/jimmunol.1002287. Epub 2011 May 27.

3.

Nondeletional T-cell receptor transgenic mice: model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection.

Chen M, Sällberg M, Thung SN, Hughes J, Jones J, Milich DR.

J Virol. 2000 Aug;74(16):7587-99.

5.

MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B cell receptor ligation facilitates switch to IgG production.

Munthe LA, Os A, Zangani M, Bogen B.

J Immunol. 2004 Jun 15;172(12):7476-84. Erratum in: J Immunol. 2005 Nov 1;175(9):6235.

6.

Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.

Oxenius A, Bachmann MF, Zinkernagel RM, Hengartner H.

Eur J Immunol. 1998 Jan;28(1):390-400.

PMID:
9485218
7.

Aborted germinal center reactions and B cell memory by follicular T cells specific for a B cell receptor V region peptide.

Heiser RA, Snyder CM, St Clair J, Wysocki LJ.

J Immunol. 2011 Jul 1;187(1):212-21. doi: 10.4049/jimmunol.1002328. Epub 2011 May 27.

8.

Modeling the T-helper cell response in acute and chronic hepatitis B virus infection using T-cell receptor transgenic mice.

Chen M, Sällberg M, Thung SN, Hughes J, Jones J, Milich DR.

Antiviral Res. 2001 Nov;52(2):99-111.

PMID:
11672819
9.

Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration.

Jones ND, Fluck NC, Roelen DL, Mellor AL, Morris PJ, Wood KJ.

Eur J Immunol. 1997 Jul;27(7):1591-600.

PMID:
9247566
10.

Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.

Haynes NM, Trapani JA, Teng MW, Jackson JT, Cerruti L, Jane SM, Kershaw MH, Smyth MJ, Darcy PK.

Blood. 2002 Nov 1;100(9):3155-63. Erratum in: Blood. 2003 May 15;101(10):3808.

11.
12.

T and B cell tolerance and responses to viral antigens in transgenic mice: implications for the pathogenesis of autoimmune versus immunopathological disease.

Zinkernagel RM, Pircher HP, Ohashi P, Oehen S, Odermatt B, Mak T, Arnheiter H, Bürki K, Hengartner H.

Immunol Rev. 1991 Aug;122:133-71. Review.

PMID:
1937540
13.
15.

New TCR transgenic model for tracking allospecific CD4 T-cell activation and tolerance in vivo.

Sandner SE, Salama AD, Houser SL, Palmer E, Turka LA, Sayegh MH.

Am J Transplant. 2003 Oct;3(10):1242-50.

17.

B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells.

Phan TG, Amesbury M, Gardam S, Crosbie J, Hasbold J, Hodgkin PD, Basten A, Brink R.

J Exp Med. 2003 Apr 7;197(7):845-60. Epub 2003 Mar 31.

18.

Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).

Griffin MD, Hong DK, Holman PO, Lee KM, Whitters MJ, O'Herrin SM, Fallarino F, Collins M, Segal DM, Gajewski TF, Kranz DM, Bluestone JA.

J Immunol. 2000 May 1;164(9):4433-42.

19.
20.

Agonist anti-human CD27 monoclonal antibody induces T cell activation and tumor immunity in human CD27-transgenic mice.

He LZ, Prostak N, Thomas LJ, Vitale L, Weidlick J, Crocker A, Pilsmaker CD, Round SM, Tutt A, Glennie MJ, Marsh H, Keler T.

J Immunol. 2013 Oct 15;191(8):4174-83. doi: 10.4049/jimmunol.1300409. Epub 2013 Sep 11.

Supplemental Content

Support Center